Secure Asset Management, LLC Gilead Sciences, Inc. Transaction History

Secure Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $205,847 - $257,949	-3,554 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $15,571 - $17,673	240 Added 7.24%	3,554 $258,000
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $178,836 - $192,945	-2,642 Reduced 44.36%	3,314 $231,000
Q2 2021 Jul 16, 2021	BUY	$63.47 - $69.35 $168,893 - $184,540	2,661 Added 80.76%	5,956 $410,000
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $197,700 - $225,575	3,295 New	3,295 $213,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Secure Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Secure Asset Management, LLC with notifications on news.